Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
11/27/2012 | CA2567349C Method of improving t cell receptors |
11/27/2012 | CA2519249C Method and system for determining insulin dosing schedules and carbohydrate-to-insulin ratios in diabetic patients |
11/27/2012 | CA2516702C Modified t cell receptor linked by disulphide bond between constant domain cysteine residues |
11/27/2012 | CA2512497C Methods and apparatus for the measurement of hydrogen sulphide and thiols in fluids |
11/27/2012 | CA2500392C Microfluidic device for cell separation and uses thereof |
11/27/2012 | CA2488404C Genes and polypeptides relating to human colon cancers |
11/27/2012 | CA2483931C Method and apparatus for isolating platelets from blood |
11/27/2012 | CA2473325C Method and/or system for analyzing biological samples using a computer system |
11/27/2012 | CA2471660C Method and reagent of colorimetry employing an oxidoreductase and a transition metal complex that changes colour by transferring an electron |
11/27/2012 | CA2452819C High throughput assay system |
11/27/2012 | CA2449157C Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
11/27/2012 | CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments |
11/27/2012 | CA2416545C Common polymorphism in scn5a implicated in drug-induced cardiac arrhythmia |
11/27/2012 | CA2413151C Host cells containing multiple integrating vectors |
11/27/2012 | CA2396778C Methods and kits for identifying elite event gat-zm1 in biological samples |
11/27/2012 | CA2359360C In vitro screening method for identifying selective binding partners for 5-ht5-receptors |
11/27/2012 | CA2347131C Modified peptides as therapeutic agents |
11/27/2012 | CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof |
11/23/2012 | DE202012009846U1 Methode zur Bestimmung der Stückzahl, des Volumens und der Güteanteile von in Form von Poltern gelagerten Holzstämmen Method for determining the quantity, volume and quality of stored shares in the form of cluttering logs |
11/22/2012 | WO2012159115A1 Methods for determining the likelihood of survival and for predicting likelihood of metastasis in cancer patients |
11/22/2012 | WO2012159084A1 Modification-dependent activity assays |
11/22/2012 | WO2012159079A1 Assay to determine lrrk2 activity in parkinson's disease |
11/22/2012 | WO2012159075A1 Bioprobe compositions and their methods of use |
11/22/2012 | WO2012159045A1 Detection of circulating adamts13-antibody complexes |
11/22/2012 | WO2012159030A1 Chromosome copy number gain as a biomarker of urothelial carcinoma lethality |
11/22/2012 | WO2012159012A1 Characterization of food materials by optomagnetic fingerprinting |
11/22/2012 | WO2012158954A1 Methods of diagnosing and treating pulmonary diseases or disorders |
11/22/2012 | WO2012158831A1 Performance of a biomarker panel for irritable bowel syndrome |
11/22/2012 | WO2012158789A2 Methods and compositions for inhibiting neddylation of proteins |
11/22/2012 | WO2012158763A1 Detecting, preventing, and treating bronchopulmonary dysplasia |
11/22/2012 | WO2012158739A1 Improved methods for the selection of binding proteins |
11/22/2012 | WO2012158684A1 Method, solvent formulation, and apparatus for the measurement of the salt content in petroleum fluids |
11/22/2012 | WO2012158640A1 Method for a key generation using genomic data and its applicaton |
11/22/2012 | WO2012158638A1 Method and apparatus for diagnosing blood parasites |
11/22/2012 | WO2012158466A1 Methods and compositions for detecting microbial production of water-immiscible compounds |
11/22/2012 | WO2012158207A2 Method for mutiplexed microfluidic bead-based immunoassay |
11/22/2012 | WO2012158123A1 Compounds and methods for treating insulin resistance syndrome |
11/22/2012 | WO2012158041A1 Diagnostic methods and kits for determining the presence of a microorganism in a sample |
11/22/2012 | WO2012158015A1 Method of quantitative measurement of mechanical stability time (mst) of latex suspensions and the apparatus for use in the method |
11/22/2012 | WO2012157821A1 Variable color two-photon fluorescent probe, method for imaging thiol activation in mitochondrion using same, and method for manufacturing the variable color two-photon fluorescent probe |
11/22/2012 | WO2012157778A1 Gene identification method in fragmentome analysis and expression analysis method |
11/22/2012 | WO2012157751A1 Diagnosis of respiratory tract infectious diseases using urine specimens |
11/22/2012 | WO2012157750A1 Diagnosis of respiratory tract infectious disease using blood specimens |
11/22/2012 | WO2012157746A1 Therapeutic drug for autoimmune disease |
11/22/2012 | WO2012157672A1 Method for predicting effectiveness of angiogenesis inhibitor |
11/22/2012 | WO2012157647A1 Method for selecting chemotherapy for gastric cancer patient using combination drug of tegafur, gimeracil and oteracil potassium and egfr inhibitor |
11/22/2012 | WO2012157589A1 Cell adhesion inhibitor, cell proliferation inhibitor, and method and kit for testing cancer |
11/22/2012 | WO2012157491A1 Egg quality-inspecting device |
11/22/2012 | WO2012157484A1 Monoclonal antibody and inspection device using same |
11/22/2012 | WO2012157237A1 Osteogenesis promoter |
11/22/2012 | WO2012157201A1 Information processing system, information processing method, information processing device, and control method and control program therefor |
11/22/2012 | WO2012156928A1 Vdac1-s as a cell marker |
11/22/2012 | WO2012156912A1 Whole -cell bacterial bio-capacitor chip and a method for detecting cellular stress induced by toxic chemicals by use of the chip |
11/22/2012 | WO2012156764A1 Method of detection of amino acid sequence and/or identification of peptides and proteins, by use of a new derivatization reagent and synthesis of 5-formyl-benzene-1,3-disulphonic acid as derivatization reagent |
11/22/2012 | WO2012156733A1 Detection and depletion of hcmv infected cells |
11/22/2012 | WO2012156669A1 Early warning system for hydrate or clathrate materials |
11/22/2012 | WO2012156665A2 Methods and compositions relating to platelet sensitivity |
11/22/2012 | WO2012156528A1 Method for the determination of the presence of an antibiotic in a fluid |
11/22/2012 | WO2012156526A1 In vitro method for predicting in vivo genotoxicity of chemical compounds |
11/22/2012 | WO2012156501A1 Signature for the diagnosis of cancer aggressiveness and genetic instability |
11/22/2012 | WO2012156476A2 Methods for screening substances capable of modulating the replication of an influenza virus |
11/22/2012 | WO2012156465A1 Methods and kits for detecting diagnosing and monitoring diseases |
11/22/2012 | WO2012156463A1 Novel cancer therapies and methods |
11/22/2012 | WO2012156452A1 Method for detecting infections |
11/22/2012 | WO2012156447A1 New biomarker for the classification of ovarian tumours |
11/22/2012 | WO2012156432A1 Device and probe for detection of infection |
11/22/2012 | WO2012156429A1 Initial relative lymphocyte count as predictive biomarker |
11/22/2012 | WO2012156420A1 Large, hs6st2 or st8sia1 activators for preventing and/or attenuating skin ageing and/or hydrating skin |
11/22/2012 | WO2012156419A2 Lmna, fnta and face-1 activators for preventing and/or attenuating skin ageing and/or hydrating skin |
11/22/2012 | WO2012156377A1 Stepwise assembled capture compounds and method for isolating proteins from complex mixtures |
11/22/2012 | WO2012156351A1 Epha4 is a disease modifier in motor neuron disease |
11/22/2012 | WO2012156330A1 Rbm3 in bladder cancer |
11/22/2012 | WO2012156313A1 Method for the diagnosis of early rheumatoid arthritis |
11/22/2012 | WO2012156216A1 Increase in storage lifetime of a thrombin sensor |
11/22/2012 | WO2012156059A1 Utilization of magnetic nanoparticles as intracellular pull-down system |
11/22/2012 | WO2012155973A1 Method and device for automatically determining the position of a microsystem for manipulating a spherical microobject |
11/22/2012 | WO2012155893A1 Nir measuring device |
11/22/2012 | WO2012155346A1 Kit for assessing fragrance intensity of fabric care product |
11/22/2012 | WO2012155204A1 Assay for detection of telomerase rna |
11/22/2012 | WO2012135844A3 Circulating exosomes as diagnostic/prognostic indicators and therapeutic targets of melanoma and other cancers |
11/22/2012 | WO2012135749A3 Biomarkers for predicting sensitivity to cancer treatments |
11/22/2012 | WO2012130618A3 Method and device for detecting parameters of a traversing or circulating material web in a material processing machine |
11/22/2012 | WO2012127454A3 Fluids detection sensor and rail, in particular for automotive fuels |
11/22/2012 | WO2012126013A3 Method for making pluripotent stem cells |
11/22/2012 | WO2012122536A3 Systems and methods for high-throughput detection of an analyte in a sample |
11/22/2012 | WO2012118915A3 Compositions and methods for treatment of tamoxifen resistant breast cancer |
11/22/2012 | WO2012116328A3 Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival |
11/22/2012 | WO2012112958A3 High-throughput assays to probe leukemia within the stromal niche |
11/22/2012 | WO2012112443A3 Anti-mucin antibodies for early detection and treatment of pancreatic cancer |
11/22/2012 | WO2012112440A3 Fluorescent potassium ion sensors |
11/22/2012 | WO2012109538A3 Surrogates of post-translationally modified proteins and uses thereof |
11/22/2012 | WO2012109258A3 Compositions adn methods for monitoring oxalate |
11/22/2012 | WO2012106652A3 Non-invasive, continuous, real-time system for determining tissue hypoperfusion |
11/22/2012 | WO2012103337A3 Assays and methods to sequence microbes directly from immune complexes |
11/22/2012 | WO2012103187A3 Methods of diagnosing and treating age-related macular degeneration |
11/22/2012 | WO2012100190A3 Identifying location biomarkers |
11/22/2012 | WO2012092295A3 Optical diagnosis of abnormal cells |
11/22/2012 | WO2012085652A3 Methods for differentiating between disease states of mycobacterium tuberculosis infection |
11/22/2012 | WO2012084895A3 Crystal structure of flt3 ligand-receptor complex |
11/22/2012 | WO2012080977A3 Device, system and method for measuring homeostasis, vitality, energy and stress in an individual or substance |